Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
The British Journal of Ophthalmology|September 5, 2023
Comparative assessment of subretinal hyper-reflective material in patients treated with brolucizumab versus aflibercept in HAWK and HARRIERSriniVas Sadda, David Sarraf, Arshad M Khanani, et al.
Frontiers in Ophthalmology|March 12, 2026
Imaging and functional correlates of fibrosis in neovascular age-related macular degeneration: a systematic reviewKimberly L Spooner, Samantha Fraser-Bell, Dun Jack Fu, et al.
Ophthalmic Research|December 5, 2015
Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration: 12-Month Safety and Efficacy OutcomesAndrew A Chang, Geoffrey K Broadhead, Thomas Hong, et al.
Ophthalmology|June 17, 2020
Macular Atrophy Incidence and Progression in Eyes with Neovascular Age-Related Macular Degeneration Treated with Vascular Endothelial Growth Factor Inhibitors Using a Treat-and-Extend or a Pro Re Nata Regimen: Four-Year Results of the MANEX StudyKimberly L Spooner, Samantha Fraser-Bell, Mariano Cozzi, et al.
Clinical & Experimental Ophthalmology|June 23, 2018
Post-surgical versus post-intravitreal injection endophthalmitis: changing patterns in causative floraAaron Pc Ong, Nikki Angbue Te, Sophia L Zagora, et al.
BMJ Open Ophthalmology|October 21, 2025
A prospective, open-label, single-arm, investigator-initiated clinical trial to assess the efficacy, safety and durability of faricimab in patients with inadequate response to current treatment for neovascular age-related macular degeneration: protocol design and rationale for the FURGGHORN StudyLong T Phan, Thomas Hong, John H Chang, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|January 23, 2019
Early Pars Plana Vitrectomy for Treatment of Acute Infective EndophthalmitisI-Van Ho, Guillermo Fernandez-Sanz, Steve Levasseur, et al.
Eye (London, England)|July 1, 2023
Lesion area progression in eyes with neovascular age-related macular degeneration treated using a proactive or a reactive regimenMariano Cozzi, Davide Monteduro, Raffaele Antonio Esposito, et al.
Investigative Ophthalmology & Visual Science|September 24, 2016
Evaluation of Nonperfused Retinal Vessels in Ischemic RetinopathyMichael B Powner, Dawn A Sim, Meidong Zhu, et al.
The British Journal of Ophthalmology|July 24, 2021
Efficacy and safety of brolucizumab versus aflibercept in eyes with polypoidal choroidal vasculopathy in Japanese participants of HAWKYuichiro Ogura, Glenn J Jaffe, Chui Ming Gemmy Cheung, et al.
Pageof 6